Unifirst Corp: Form 10-Q for the period ended Mar 1, 2025
Filed with the SEC on Apr 10, 2025 and accepted by EDGAR at Apr 10, 2025, 15:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-01. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-12-01 to 2025-03-01 | $602.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2024-09-01 to 2025-03-01 | $1.21bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-12-01 to 2025-03-01 | $394.1m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2024-09-01 to 2025-03-01 | $775.2m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2024-12-01 to 2025-03-01 | $141.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2024-09-01 to 2025-03-01 | $275.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-12-01 to 2025-03-01 | $31.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2024-09-01 to 2025-03-01 | $86.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-12-01 to 2025-03-01 | $8.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2024-09-01 to 2025-03-01 | $23.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-12-01 to 2025-03-01 | $24.5m | us-gaap:NetIncomeLoss |
| Net income | 6 months2024-09-01 to 2025-03-01 | $67.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-12-01 to 2025-03-01 | $1.31 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2024-09-01 to 2025-03-01 | $3.62 | us-gaap:EarningsPerShareDiluted |
| Diluted shares (weighted) | 3 months2024-12-01 to 2025-03-01 | 18,649,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2024-09-01 to 2025-03-01 | 18,653,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2024-09-01 to 2025-03-01 | $128.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2024-09-01 to 2025-03-01 | $66.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2024-09-01 to 2025-03-01 | $12.2m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2024-09-01 to 2025-03-01 | $12.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-03-01 | $192.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-03-01 | $936.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-01 | $2.73bn | us-gaap:Assets |
| Current liabilities | At period end2025-03-01 | $277.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-01 | $589.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-03-01 | $2.14bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-25-052817. Last ingested by Listed: Nov 3, 2026, 21:35 ET. Listed shows no prices and gives no investment advice.